Laboratory Animals Market Overview
The Laboratory Animals Market is expanding as demand for biomedical research, drug development, toxicology testing, and genetics research continues to increase. Rising investments in pharmaceutical and biotechnology research, growing chronic disease studies, advancements in genetic engineering, and increasing demand for specialized research models are supporting market growth.
According to the WiseGuyReports market report published in June 2026, the global Laboratory Animals Market was valued at USD 4.6 Billion in 2024 and is projected to grow from USD 4.8 Billion in 2025 to USD 7.2 Billion by 2035, registering a CAGR of 4.1% during 2026–2035. North America is expected to dominate the market, with the regional market valued at USD 2.0 Billion in 2024 and projected to reach USD 3.0 Billion by 2035. The Rodents segment was valued at USD 2.4 Billion in 2024 and is projected to reach USD 3.6 Billion by 2035.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.wiseguyreports.com/sample-request?id=582883
Key players driving innovation and competitiveness in the Laboratory Animals Market include:
Crown Bioscience
Janvier Labs
Cyagen Biosciences
KWS SAAT SE
Sage Science
Biomedical Research Models
InVivo Biosystems
Taconic Biosciences
Push Bio
Charles River Laboratories International
The Jackson Laboratory
Harlan Laboratories
Envigo
The market is being shaped by increasing research and development investments, growing demand for animal models in drug development, and advancements in genetic engineering and breeding technologies. Pharmaceutical and biotechnology companies are increasingly using specialized laboratory animals for toxicity testing, disease research, genetics research, and therapeutic development. At the same time, ethical concerns and regulatory requirements are encouraging the development of alternative testing methods and improved animal welfare practices.
The Laboratory Animals Market can be segmented by Type into Rodents, Birds, Fish, Reptiles, and Non-human Primates. By Application, it includes Drug Development, Biotechnology, Toxicology, Genetics Research, and Disease Research. By End User, it covers Academic Institutions, Pharmaceutical Companies, Biotechnology Companies, and Contract Research Organizations. Regionally, the market covers North America, Europe, South America, Asia Pacific, and the Middle East and Africa.
The growing need for reliable research models is creating opportunities for laboratory animal suppliers, pharmaceutical companies, biotechnology firms, academic institutions, and contract research organizations. Genetically engineered models, humanized animal models, advanced breeding technologies, digital data platforms, and alternative testing approaches can support market differentiation and future growth.
Recent Developments and Market Trends:
Increasing pharmaceutical and biotechnology research is driving demand for laboratory animals in drug development and safety testing.
Genetic engineering and advanced breeding technologies are enabling the development of more specialized and disease-specific research models.
Rodents, particularly mice and rats, continue to account for a major share of laboratory animal use because of their applications in genetics, toxicology, and biomedical research.
Growing interest in zebrafish and other non-traditional models is creating additional opportunities for specific research applications.
Ethical concerns and stricter animal welfare regulations are encouraging researchers to adopt humane practices and explore alternative testing methods.
Organ-on-a-chip technologies, in vitro testing, and computerized modeling are emerging as complementary approaches that can reduce reliance on traditional laboratory animals.
Reasons to Buy the Report:
Provides comprehensive insights into the Laboratory Animals Market dynamics, trends, opportunities, and growth potential.
Helps identify opportunities across rodents, birds, fish, reptiles, and non-human primates.
Offers detailed segmentation analysis across type, application, end user, and geographic markets.
Includes competitive intelligence covering leading laboratory animal suppliers, pharmaceutical companies, biotechnology companies, and research organizations.
Supports informed decisions using market forecasts, R&D investment trends, genetic engineering advancements, biopharmaceutical growth, ethical considerations, and regional opportunities.
Future Outlook:
The future of the Laboratory Animals Market will be shaped by increasing biomedical research, growing pharmaceutical and biotechnology investments, advancements in genetic engineering, rising chronic disease research, and the development of alternative testing technologies. Rodents should remain the leading type segment, with the segment projected to increase from USD 2.4 Billion in 2024 to USD 3.6 Billion by 2035. North America is expected to retain its leadership position, with the regional market projected to grow from USD 2.0 Billion in 2024 to USD 3.0 Billion by 2035. Asia Pacific is positioned for strong growth as biopharmaceutical investments, research infrastructure, and healthcare spending increase. The global Laboratory Animals Market is projected to reach USD 7.2 Billion by 2035 at a CAGR of 4.1%.
➤➤Explore Our Latest Related Reports:
